Includes the development of a model capable of evaluating the medical and economic consequences of several breast cancer prevention options.  Through Monte Carlo simulations, the model will provide population-level estimates of the consequences for women with different levels of risk to breast cancer and different levels of susceptibility to the side effects of each option.